Cash incentives for HIV testing

An HIV prevention intervention in which young people who had tested negative for sexually transmitted infections were given lottery tickets and had the possibility of winning a cash prize reduced the number of HIV infections by 39% in young women, researchers reported to the 7th International AIDS Society conference (IAS 2013) this week. However, the intervention did not have any impact on young men in this trial in Lesotho.

The conference also heard results of an intervention in Vancouver, Canada to improve engagement of drug users in HIV testing and post-test follow-up. It is generally more feasible to use financial incentives to facilitate a discrete, time-limited health behaviour such as testing or vaccination, in contrast to sustained sexual behaviour change, as seen in Lesotho.

Roger Pebody
aidsmap
Read More

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below